Authors/Disclosures
|
|
No disclosure on file |
|
Anna Ranta, MD, PhD, FRACP, FAAN
(University of Otago, Wellington)
|
The institution of Dr. Ranta has received research support from Health Research Council of New Zealand. The institution of Dr. Ranta has received research support from New Zealand Ministry of Health. The institution of Dr. Ranta has received research support from New Zealand Neurological Foundation. Dr. Ranta has a non-compensated relationship as a Treasurer with Stroke Society of Australasia that is relevant to AAN interests or activities. Dr. Ranta has a non-compensated relationship as a Board Member with World Stroke Organisation that is relevant to AAN interests or activities. Dr. Ranta has a non-compensated relationship as a President with Neurological Association of new Zealand that is relevant to AAN interests or activities. Dr. Ranta has a non-compensated relationship as a Editorial Board Member with 'Stroke' and 'Neurology' (Journals) that is relevant to AAN interests or activities. |
|
Monika Manchanda, MD
(University of New Mexico)
|
Dr. Manchanda has nothing to disclose. |
|
Emmanuel Roze, MD, PhD
|
Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merz. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving as a Consultant for orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aguettant. The institution of Dr. Roze has received research support from merz. The institution of Dr. Roze has received research support from Orkyn. Dr. Roze has received research support from elivie. The institution of Dr. Roze has received research support from allergan. The institution of Dr. Roze has received research support from fondation desmarest. The institution of Dr. Roze has received research support from everpharma. Dr. Roze has received research support from AMADYS. The institution of Dr. Roze has received research support from ADCY5.org. The institution of Dr. Roze has received research support from agence nationale de la recherche. The institution of Dr. Roze has received research support from société française de médecine esthétique. The institution of Dr. Roze has received research support from dystonia medical research foundation. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Suzanne J. Busch, MD
(Nelson Marlborough DHB)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Nathalie Patte
|
No disclosure on file |
|
Gilles Fenelon, MD, PhD
|
No disclosure on file |
|
Francois Viallet, MD
(Centre Hospitalier Regional)
|
No disclosure on file |
|
Marie Vidailhet, MD, PhD
(Salpetriere Hospital)
|
No disclosure on file |
|
Pierre Pollak, MD
|
No disclosure on file |
|
Emmanuelle Apartis, MD
|
No disclosure on file |